Syndax Pharmaceuticals Inc (SNDX) Implied Volatility Current

Tracking SNDX implied volatility helps you identify when options premiums on Syndax Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Syndax Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when SNDX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Syndax Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For SNDX, tracking metrics like SNDX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on SNDX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat.

It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where SNDX implied volatility sits today versus where it has been. Our scanner ranks Syndax Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in SNDX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Syndax Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.